Next COVID-19 Drug Target: Viral “Molecular Scissor”
Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins. American and Polish scientists, reporting October 16, 2020, in the journal Science…
Coronavirus uses enzymatic cutter for virus production and to disable essential immune proteins. American and Polish scientists, reporting October 16, 2020, in the journal Science…
Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage While the world waits eagerly for a safe and effective vaccine to prevent…
Test could inform doctors on best treatment options. Scientists have developed, for the first time, a score that can accurately predict which patients will develop…
Countries with international travel restrictions suffered fewer COVID-19 fatalities. Travel restrictions implemented early on in the pandemic have been crucial in slowing the spread of…
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in…
In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients….
New light is being shed on a little-known role of Y chromosome genes, specific to males, that could explain why men suffer differently than women…
Model developed by Brazilian researchers predicts spatial and temporal evolution of epidemic diseases and can help plan more effective social isolation programs with less socio-economic…
In a new COVID-19 clinical trial, UC Davis Health tests the same REGN-COV2 antibody combination given to President Trump. In a new clinical trial, UC…
Individuals with blood type O may have lowest risk of infection; individuals with A and AB may have increased risk of severe clinical outcomes. Two…
In this study, which was recently published in the journal Frontiers in Immunology, researchers used sequencing to characterize the immune system of patients who survive…
One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how…
Scientists in the US and UK publish first in-depth look at how CD4+ T cells fight SARS-CoV-2. As scientists around the world develop life-saving COVID-19…
The vast majority of SARS-CoV-2 transmission occurs indoors, most of it from the inhalation of airborne particles that contain the coronavirus. The best way to…
States that reopened sooner, such as Texas, Arizona, and Florida, experienced summer surges, report says. For every two deaths attributed to COVID-19 in the U.S.,…
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the…
The pilot project is designed to determine if wastewater testing can provide early signals about the spread of the virus. Last week, MIT began piloting…
Front-line health workers had similar infection rates whether they took a daily regimen of hydroxychloroquine or not. In a clinical trial testing whether a daily…